Project Grant R41HL176279
Award Date
9/15/24
Completion Date
12/5/24
Dollars Obligated
-$398K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded $274,440 to Vine Medical Inc., a for-profit manufacturing company, to develop a proof-of-concept for a self-deploying endotracheal intubation device. The proposed soft robotics system aims to achieve over a 90% first-pass intubation success rate, which would improve patient outcomes and reduce complications during emergency airway management procedures. The device is designed to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $295,924 to Convergent Engineering, Inc. to develop a prototype decision support system for personalized mechanical ventilation care. The system aims to simplify the use of esophageal pressure measurements to optimize ventilator settings and prevent complications for ventilated patients. The project has two key objectives: 1) Building a...
This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $274,841 to XN Health Inc. to develop a novel transtracheal phrenic nerve stimulation device. The device aims to reduce injury rates caused by mechanical ventilation by stimulating the phrenic nerves to induce diaphragmatic contractions, thereby increasing lung inflation and supporting protective ventilation for critically ill patients. The...
This $256,000 National Science Foundation project grant supports the development of an automated chest tube to prevent clotting. Circulatech LLC will design and prototype a novel chest tube that proactively manages fluid flow within the catheter lumen to flush and drain the tube, reducing blood clot formation. Through a process called "dilutional coagulopathy," the tube will use sterile saline or anticoagulants to reduce thrombosis in the drainage space rather than relying on...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $1,160,157 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Liberandum Technologies, Inc. to develop and test a bidirectional synchronous flow-controlled ventilation system called "VentSafe" to improve oxygenation and ventilation in patients with Acute Respiratory Distress Syndrome (ARDS). The goal of this Phase 1 Small Business Innovation Research (SBIR) project is to overcome the limitations of...
This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop and test a drug-eluting chest tube to locally manage the pain associated with its use in cardiothoracic surgeries. The $275,752 award supports two key objectives: 1) completing GMP/GLP studies on the drug release kinetics, stability, and manufacturing of the drug-releasing chest tube; and 2) evaluating the mechanical...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $395,306 to Cutcath LLC to develop and evaluate a novel electrosurgical catheter device for treating acute aortic dissection. The device, called the Cutcath Dissection Septum Cutting Catheter (DSCC), aims to facilitate more effective endovascular aortic repair (TEVAR/EVAR) by allowing complete fenestration of the aortic dissection septum....
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $571,410 to Pharynvac Surgical Technology Inc. to develop a novel device called "Pharynvac" that can mitigate key issues in sinonasal surgeries. Specifically, the Pharynvac device aims to reduce surgical staff exposure to pathogens and toxins, prevent...